Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation - Test2 - elhamkhani - TriplyDB

Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation

Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation

http://www.wikidata.org/entity/Q35174654

about

Opioid-induced constipation: advances and clinical guidance Evolving paradigms in the treatment of opioid-induced bowel dysfunction Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation The role of naloxegol in the management of opioid-induced bowel dysfunction Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities Safety concerns with long-term opioid use.Prevalence and clinical features of opioid-induced constipation in the general population: A French study of 15,000 individuals Opioid-Induced Constipation.Patient preferences for change in symptoms associated with opioid-induced constipation.Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain.An appraisal of clinical practice guidelines for constipation: a right attitude towards to guidelines.Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects Efficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate response Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation When People with Opioid-Induced Constipation Speak: A Patient Survey.Naloxegol: a review of its use in patients with opioid-induced constipation.A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.Management of opioid-induced constipation for people in palliative care.New Options in Constipation Management.Opioid-induced constipation, use of laxatives, and health-related quality of life.Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.Diagnosis and management of chronic constipation in adults.Opioid-Related Constipation in Patients With Non-cancer Pain Syndromes: a Review of Evidence-Based Therapies and Justification for a Change in Nomenclature.Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications.Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem.Opioid-Induced Constipation Survey in Patients with Chronic Noncancer Pain.The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study.Opioid analgesic use among patients presenting with acute abdominal pain and factors associated with surgical diagnoses.High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain.Peripherally Acting µ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.Oral prolonged-release oxycodone/naloxone for managing pain and opioid-induced constipation: A review of the evidence.Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.Managing opioid-induced constipation.

P2860

Q26765571-59215DBF-A627-4D88-A6C7-6783834F512E Q26777692-03E9C18E-3D3E-4B7F-82B8-1C7520F9A47C Q26830397-EE833ABC-3248-483D-9B3D-FCBBEAFF4EEB Q28072039-5850B81B-4790-43FB-8E35-D84AC3480E04 Q28083547-EE2D1275-DE34-4073-BD4C-E8AD68B2A866 Q30251602-5682C1A8-4F60-4005-A0F2-FEBF10E4A11A Q33731958-D7259044-8325-4B0E-A875-3410074A151F Q34497803-86C963A1-E971-46F1-8BF4-9367956BF940 Q34737112-367FB8D2-2C1C-41D8-878A-479B9CEF3FDB Q35485683-AF31D918-3E16-4973-AF90-10F4D2F95431 Q36007914-2F64396A-944C-4D00-9D07-390AEC6A4660 Q36044477-215BACE0-BFD8-48C2-91FA-9FC0053A6B47 Q36223541-B030F625-7C64-4AB2-B824-A20D12FC998E Q36384732-B480D856-35D5-4263-98BB-B795A77EA9CE Q37018248-4887FD9E-365F-4994-94FF-9D2B811CB5C4 Q37233788-DE7C49F3-0B1D-4C16-B6CD-8B6D5E3C9C4A Q37699688-98067A60-DE55-4FB4-A8FE-CDB1E3FF4EA7 Q38349821-12626F1D-BD26-4B44-ACC0-90CE2C938F60 Q38378588-03819AFB-1960-477C-BB2E-87D93FCEE355 Q38540868-623E92A0-891E-4173-A18F-9659A24DCA9B Q38602701-52C6FAD3-639E-4D92-B438-E0CF56A24B2C Q38603877-40489E72-6773-4394-A8AC-47E6D6B850C7 Q38761898-588706EC-2F0B-4A23-B262-E5B571994B5C Q38794996-1990B97E-56BB-43F9-B1DC-D0F5B8A066B0 Q38880480-09CA9410-4773-4922-829E-F3C7A4187F63 Q38911748-01B42753-EDFD-400C-97ED-C76D217183BA Q39051851-0AEC27B1-E8E6-4A4C-91E7-E7DF56C9E35F Q39151326-9D3F3FBD-1112-4231-BD76-02CB335FCE88 Q39151954-4FA0F8D2-E2E8-4745-B8D6-225DE5CC5CFD Q39175152-E8428ACC-577C-48DA-A9AB-15223AF08BBE Q40238200-573ABDC8-D7D2-419F-8141-3D3BE177370A Q40407348-3C3E60F7-A7A3-41FA-A1AC-D2B23FBCAFA0 Q40532932-74E63586-57B4-448E-BFEC-E1601FFAC93F Q42695148-9693C3AC-17B0-4997-934B-343B33DBBC12 Q43062741-C07D96DC-54F1-479F-8431-979D0362F18E Q43075620-C354746F-38E7-43D3-A5F9-C351F34B6129 Q43075966-AF7A121D-9969-4BE7-A1B0-9F54ED4F4004 Q43075972-3570218C-E86F-4A23-80E7-B70F2BC9049C Q43365484-5666253F-CFF9-4819-8B96-5396D35EA58D Q44333986-BC144DEA-D9E5-45B7-BE7A-50942F38C501

P2860

Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation

http://www.wikidata.org/entity/Q35174654

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Emerging treatments in neuroga ...... on opioid-induced constipation

@ast

Emerging treatments in neuroga ...... on opioid-induced constipation

@en

type

label

Emerging treatments in neuroga ...... on opioid-induced constipation

@ast

Emerging treatments in neuroga ...... on opioid-induced constipation

@en

prefLabel

Emerging treatments in neuroga ...... on opioid-induced constipation

@ast

Emerging treatments in neuroga ...... on opioid-induced constipation

@en

P1433

Q35174654-35A8E65F-C2C7-47E2-B135-6E3900E7F609

P1476

Q35174654-D43C586C-2B93-402C-BE3E-7D83F5FE7BD0

P2093

Q35174654-045F0924-41E4-4BC3-9066-3BD325BC5A8E

Q35174654-08D4BB0B-A36F-4A14-892B-8B28F6555724

Q35174654-295A884C-BCF2-41AE-AB43-9C6DE6A81405

Q35174654-5D61AC69-64AC-4C5E-9490-4914EF8EAB53

Q35174654-F2CB7997-D0C7-4369-9597-956D03116C10

P2860

Q35174654-0584F48B-48FB-49BE-AF4C-066CBEAFD9A4

Q35174654-074D615E-7A43-4D23-BFB8-B3C072C1FD5A

Q35174654-0DF3CFAB-DC2B-4B7D-8421-A9559C0A7B47

Q35174654-1145F4F7-71C9-42B6-A510-C7751A8A6F0C

Q35174654-127ABB58-28DD-49C1-B1AA-2A8C74FD02FD

Q35174654-1310467B-923B-43A2-B818-42B8A6685752

Q35174654-1BAC33D5-2254-4A74-B2A9-91AA655176D1

Q35174654-20676EF3-EE39-484F-8B6E-241F55BA46C0

Q35174654-24C63393-DDC4-41C1-BEC6-78250FB4DF76

Q35174654-25A6D279-1329-4171-9BDE-5E93A996C135

P304

Q35174654-537D06FA-2C97-4060-BE33-D0929099D38B

P31

Q35174654-A0110EBE-2F40-487D-8FE3-108532F0D21F

P356

Q35174654-CD4DBF69-F194-4B53-96BA-F38B0836C894

P433

Q35174654-9B51E105-A7F6-4FD4-AFE4-DEFED11B0897

P478

Q35174654-B0126FDC-EB1C-4E9D-84A4-61F67E6B6EAB

P50

Q35174654-0F8BA18A-1392-4D99-A97A-F0CE255E50C2

P577

Q35174654-02E4AA02-1160-4C47-A8AC-EC4E70B89696

P5875

Q35174654-4302185C-4CC5-49E1-9FD8-96B510F7FEF0

P698

Q35174654-DEAC4D0C-5C6A-4E1D-915F-ABAC1452F28A

P932

Q35174654-E897FADD-02FC-45BC-B48B-E7DC5837FA73

P356

P1433

Neurogastroenterology and Motility

P1476

Emerging treatments in neuroga ...... on opioid-induced constipation

@en

P2093

D A Drossman

http://www.w3.org/2001/XMLSchema#string

G Becker

http://www.w3.org/2001/XMLSchema#string

G M Mawe

http://www.w3.org/2001/XMLSchema#string

L R Webster

http://www.w3.org/2001/XMLSchema#string

M Camilleri

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of constipation

Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden

Opioids in chronic non-cancer pain: systematic review of efficacy and safety.

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

Defecation frequency and timing, and stool form in the general population: a prospective study.

Incidence, prevalence, and management of opioid bowel dysfunction.

Opiate-induced oesophageal dysmotility.

Effect of irritant purgatives on the myenteric plexus in man and the mouse.

P304

1386-1395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/NMO.12417

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Andrew N. Davies

P577

2014-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265131175

http://www.w3.org/2001/XMLSchema#string

P698

25164154

http://www.w3.org/2001/XMLSchema#string

P932

4358801

http://www.w3.org/2001/XMLSchema#string